C
Clinical Partners
Trial sites, imaging networks, investigator-led collaborations.
Partnering
Partnering for impact
NuclearMediX is a product-led biotech building a platform-driven portfolio. We partner selectively to accelerate translation, manufacturing scale, and global access.
Partnering Pathways
Collaboration across the ecosystem
M
Manufacturing
Cassette validation, good manufacturing practice (GMP) production and distribution routes.
P
Pharma / Biotech
Target collaboration, ligand pairing, theranostic programmes.
T
Technology
Automation, quality control (QC), cassette workflows and standard operating procedures (SOPs).
What we offer
A clear value exchange anchored in validated biology and scalable design
- Clinically informed programme strategy.
- Cassette-compatible manufacturing design.
- Scalable 18F-first approach for broad access.
- Modular framework for diagnostic-to-therapy expansion.
- Scientific expertise in radiochemistry and translation.
Collaboration Formats
Joint Development
Shared programme development around validated targets and translation strategy.
Regional Licensing
Market access models for partners able to support local clinical and manufacturing routes.
Manufacturing Supply
Hospital and contract radiopharmacy collaboration around cassette-enabled workflows.
Patient access
50%
10×
3×
Building reliable radiotracer supply
We work with clinical and manufacturing partners to address tracer availability, production capacity and distribution.
Supply-demand gap in SSTR-targeted PET tracer access reported in company materials.
Platform design intended to support higher production volume through 18F radiochemistry.
Potential distribution reach improvement versus shorter-lived alternatives.
Start a conversation
To explore partnering, contact us with your collaboration type: clinical, manufacturing, BD, or investment.